Ex-Synthes employee fights back in generic device tussle

Synthes is fighting an ex-employee in court alleging, among other things, illegal use of proprietary information. John Marotta is trying to make generic medical devices--and he may have hit on a good business model. "The payers are moving in our direction," said Marotta, CEO of Emerge Medical and former Synthes sales consultant. "If you have a $6,000 total knee replacement and a $3,000 total knee replacement that is substantially equivalent, with the same clinical outcome, the market will choose the $3,000 knee." And this week, his attorney decided to fight back, filing a counterclaim in federal court accusing Synthes of antitrust violations, making misleading statements and trying to crush Emerge through litigation. Item

Suggested Articles

Akoya Biosciences raised $50 million to help boost its commercialization in research, drug development and clinical testing markets.

The dream of a comfortable, tabletop blood testing device, needing only a few drops taken from a finger and a handful of minutes, has now arrived.

Novartis is now teaming up with Amazon’s mammoth cloud computing division to overhaul its manufacturing, supply and business operations.